Literature DB >> 19336242

The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review.

John McGeary1.   

Abstract

In addition to the large literatures on associations of the DRD4 VNTR polymorphism with ADHD and personality traits, there is an emerging literature linking this variant to addiction and addiction-related phenotypes. When only diagnosis-based studies are considered, an inconsistent picture emerges raising doubts as to the relevance of this polymorphism to addiction. However the use of multiple levels of analysis in examining the importance of this polymorphism has raised the possibility of an urge-related "intermediate phenotype" that puts one at risk for developing addiction but may not be found in all persons with an addiction diagnosis. From cellular assays through neuroimaging and behavioral phenotypes, these studies highlight the power of the "intermediate phenotype" approach and suggest a possible explanation of the mixed findings when diagnosis is used as the phenotype. Strengths and weaknesses of alternative DRD4 VNTR genotype grouping strategies are discussed. In sum, converging evidence across multiple methodologies supports the possibility of a robust relationship between the DRD4 exon 3 VNTR polymorphism and urge for addictive substances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336242      PMCID: PMC2706302          DOI: 10.1016/j.pbb.2009.03.010

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  64 in total

1.  Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents?

Authors:  Nicolas Ballon; Sophie Leroy; Christianne Roy; Marie-Chantal Bourdel; Jean-Pierre Olie; Aimé Charles-Nicolas; Marie-Odile Krebs; Marie-France Poirier
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

2.  DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.

Authors:  F Joseph McClernon; Kent E Hutchison; Jed E Rose; Rachel V Kozink
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

3.  Association study between genetic polymorphisms in the 14-3-3 eta chain and dopamine D4 receptor genes and alcoholism.

Authors:  H Ishiguro; T Saito; H Shibuya; T Arinami
Journal:  Alcohol Clin Exp Res       Date:  2000-03       Impact factor: 3.455

4.  A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse.

Authors:  S Cevoli; M Mochi; C Scapoli; N Marzocchi; G Pierangeli; L A Pini; P Cortelli; P Montagna
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

5.  Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional alleles of the catechol-o-methyltransferase (COMT) gene.

Authors:  D J Vandenbergh; L A Rodriguez; E Hivert; J H Schiller; G Villareal; E W Pugh; H Lachman; G R Uhl
Journal:  Am J Med Genet       Date:  2000-10-09

6.  Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?

Authors:  Manfred Laucht; Katja Becker; Mahha El-Faddagh; Erika Hohm; Martin H Schmidt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-05       Impact factor: 8.829

7.  Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects.

Authors:  M Kotler; H Cohen; R Segman; I Gritsenko; L Nemanov; B Lerer; I Kramer; M Zer-Zion; I Kletz; R P Ebstein
Journal:  Mol Psychiatry       Date:  1997-05       Impact factor: 15.992

8.  Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.

Authors:  Agnes Szilagyi; Krisztina Boór; Anna Székely; Péter Gaszner; Huba Kalász; Mária Sasvári-Székely; Csaba Barta
Journal:  Neuropsychopharmacol Hung       Date:  2005-03

9.  Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.

Authors:  Kent E Hutchison; Angela Wooden; Robert M Swift; Andrew Smolen; John McGeary; Lawrence Adler; Lyndee Paris
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

10.  Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.

Authors:  Francesca M Filbey; Lara Ray; Andrew Smolen; Eric D Claus; Amy Audette; Kent E Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

View more
  54 in total

1.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

2.  The association of exon 3 VNTR polymorphism of the dopamine receptor D4 (DRD4) gene with alcoholism in Mexican Americans.

Authors:  Yanlei Du; Min Yang; Hung-Wen Yeh; Yu-Jui Yvonne Wan
Journal:  Psychiatry Res       Date:  2010-04-01       Impact factor: 3.222

3.  The interaction between the dopamine receptor D4 (DRD4) variable number tandem repeat polymorphism and perceived peer drinking norms in adolescent alcohol use and misuse.

Authors:  Aesoon Park; Jueun Kim; Michelle J Zaso; Stephen J Glatt; Kenneth J Sher; Lori A J Scott-Sheldon; Tanya L Eckert; Peter A Vanable; Kate B Carey; Craig K Ewart; Michael P Carey
Journal:  Dev Psychopathol       Date:  2016-02-23

Review 4.  Pharmacogenetics of alcohol use disorder treatments: an update.

Authors:  Emily E Hartwell; Henry R Kranzler
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-11       Impact factor: 4.481

5.  Genetic associations with intimate partner violence in a sample of hazardous drinking men in batterer intervention programs.

Authors:  Gregory L Stuart; John E McGeary; Ryan C Shorey; Valerie S Knopik; Kayla Beaucage; Jeff R Temple
Journal:  Violence Against Women       Date:  2014-04

6.  Differential regulation of schizophrenia-associated microRNA gene function by variable number tandem repeats (VNTR) polymorphism.

Authors:  Mohammed Mamdani; Gowon O McMichael; Venkat Gadepalli; Vernell Williamson; Erin K Parker; Vahram Haroutunian; Vladimir I Vladimirov
Journal:  Schizophr Res       Date:  2013-11-07       Impact factor: 4.939

7.  A differential susceptibility analysis reveals the "who and how" about adolescents' responses to preventive interventions: tests of first- and second-generation Gene × Intervention hypotheses.

Authors:  Gene H Brody; Tianyi Yu; Steven R H Beach
Journal:  Dev Psychopathol       Date:  2015-02

8.  Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.

Authors:  A M Leventhal; S P David; M Brightman; D Strong; J E McGeary; R A Brown; E E Lloyd-Richardson; M Munafò; G R Uhl; R Niaura
Journal:  Pharmacogenomics J       Date:  2010-07-27       Impact factor: 3.550

9.  Associations between dopamine D4 receptor gene variation with both infidelity and sexual promiscuity.

Authors:  Justin R Garcia; James MacKillop; Edward L Aller; Ann M Merriwether; David Sloan Wilson; J Koji Lum
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior.

Authors:  Reginald Cannady; Jennifer A Rinker; Sudarat Nimitvilai; John J Woodward; Patrick J Mulholland
Journal:  Handb Exp Pharmacol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.